| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Vectors | 115 | 2024 | 3392 | 9.640 |
Why?
|
| Lentivirus | 63 | 2024 | 508 | 7.350 |
Why?
|
| Induced Pluripotent Stem Cells | 45 | 2024 | 1857 | 4.210 |
Why?
|
| Retroviridae | 27 | 2021 | 850 | 3.890 |
Why?
|
| Hematopoietic Stem Cells | 57 | 2024 | 3396 | 3.380 |
Why?
|
| Alpharetrovirus | 13 | 2021 | 29 | 3.340 |
Why?
|
| Transduction, Genetic | 46 | 2021 | 901 | 3.240 |
Why?
|
| Transgenes | 34 | 2023 | 1009 | 3.040 |
Why?
|
| Immunotherapy, Adoptive | 17 | 2024 | 1463 | 2.950 |
Why?
|
| Granulomatous Disease, Chronic | 8 | 2021 | 173 | 2.090 |
Why?
|
| Severe Combined Immunodeficiency | 8 | 2024 | 226 | 2.090 |
Why?
|
| Killer Cells, Natural | 19 | 2023 | 2202 | 1.990 |
Why?
|
| Gene Transfer Techniques | 21 | 2020 | 1205 | 1.610 |
Why?
|
| DNA Nucleotidyltransferases | 6 | 2016 | 176 | 1.600 |
Why?
|
| Receptors, Antigen, T-Cell | 11 | 2023 | 2531 | 1.500 |
Why?
|
| Cell Differentiation | 53 | 2024 | 11526 | 1.380 |
Why?
|
| Promoter Regions, Genetic | 32 | 2024 | 5778 | 1.370 |
Why?
|
| T-Lymphocytes | 22 | 2024 | 10188 | 1.310 |
Why?
|
| Genetic Engineering | 11 | 2021 | 933 | 1.300 |
Why?
|
| Hematopoiesis | 14 | 2024 | 2049 | 1.270 |
Why?
|
| Leukemia Virus, Murine | 7 | 2013 | 94 | 1.260 |
Why?
|
| Cell Tracking | 3 | 2018 | 138 | 1.230 |
Why?
|
| Mutagenesis, Insertional | 17 | 2021 | 656 | 1.220 |
Why?
|
| Terminal Repeat Sequences | 8 | 2014 | 70 | 1.150 |
Why?
|
| Gene Silencing | 10 | 2020 | 1509 | 1.100 |
Why?
|
| Receptors, Antigen | 2 | 2017 | 51 | 1.090 |
Why?
|
| Mice | 144 | 2024 | 81402 | 1.060 |
Why?
|
| Pluripotent Stem Cells | 9 | 2024 | 800 | 1.060 |
Why?
|
| Animals | 185 | 2024 | 168253 | 1.050 |
Why?
|
| Gene Expression | 28 | 2021 | 7582 | 1.040 |
Why?
|
| Cytotoxicity, Immunologic | 7 | 2020 | 1351 | 1.030 |
Why?
|
| Leukemia, Myeloid, Acute | 13 | 2022 | 3610 | 1.020 |
Why?
|
| Myeloid Cells | 8 | 2020 | 823 | 0.990 |
Why?
|
| Neomycin | 1 | 2024 | 93 | 0.950 |
Why?
|
| Virus Assembly | 3 | 2016 | 139 | 0.870 |
Why?
|
| Fibroblasts | 19 | 2022 | 4106 | 0.860 |
Why?
|
| Cell Line | 38 | 2024 | 15598 | 0.860 |
Why?
|
| Plasmids | 6 | 2020 | 2274 | 0.830 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 2 | 2021 | 36 | 0.800 |
Why?
|
| Virus Integration | 11 | 2017 | 304 | 0.770 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 19 | 2024 | 5663 | 0.760 |
Why?
|
| Anemia, Diamond-Blackfan | 5 | 2023 | 136 | 0.720 |
Why?
|
| Genes, Reporter | 5 | 2018 | 1528 | 0.720 |
Why?
|
| Gene Targeting | 7 | 2020 | 838 | 0.710 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2020 | 20 | 0.690 |
Why?
|
| Tetracycline | 7 | 2018 | 219 | 0.690 |
Why?
|
| Tetracyclines | 1 | 2020 | 65 | 0.680 |
Why?
|
| Leukemia | 7 | 2023 | 1522 | 0.670 |
Why?
|
| Receptors, CXCR4 | 4 | 2020 | 727 | 0.670 |
Why?
|
| Gammaretrovirus | 6 | 2017 | 24 | 0.650 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 4 | 2014 | 23 | 0.640 |
Why?
|
| Cells, Cultured | 44 | 2024 | 18955 | 0.640 |
Why?
|
| Lymphoma, T-Cell | 1 | 2021 | 304 | 0.640 |
Why?
|
| Interleukin-12 | 1 | 2021 | 583 | 0.630 |
Why?
|
| Neoplasms | 17 | 2024 | 22083 | 0.630 |
Why?
|
| Disease Models, Animal | 37 | 2024 | 18216 | 0.620 |
Why?
|
| Luminescent Proteins | 2 | 2018 | 836 | 0.620 |
Why?
|
| Cell Separation | 6 | 2019 | 1720 | 0.620 |
Why?
|
| Clone Cells | 8 | 2022 | 1660 | 0.620 |
Why?
|
| Rhabdomyosarcoma | 1 | 2021 | 358 | 0.610 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 3 | 2008 | 83 | 0.610 |
Why?
|
| Endothelium | 1 | 2021 | 765 | 0.610 |
Why?
|
| Cisplatin | 1 | 2024 | 1647 | 0.610 |
Why?
|
| Humans | 218 | 2024 | 760437 | 0.600 |
Why?
|
| Bone Marrow Cells | 13 | 2020 | 2416 | 0.600 |
Why?
|
| Teratoma | 2 | 2018 | 402 | 0.580 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 687 | 0.570 |
Why?
|
| Mesenchymal Stem Cells | 8 | 2023 | 1636 | 0.570 |
Why?
|
| Genetic Diseases, X-Linked | 5 | 2021 | 386 | 0.560 |
Why?
|
| Flow Cytometry | 16 | 2021 | 5865 | 0.560 |
Why?
|
| RNA, Messenger | 12 | 2021 | 12785 | 0.550 |
Why?
|
| Pulmonary Alveolar Proteinosis | 4 | 2019 | 40 | 0.550 |
Why?
|
| Homeodomain Proteins | 9 | 2021 | 2413 | 0.540 |
Why?
|
| Integrases | 7 | 2016 | 516 | 0.540 |
Why?
|
| Cell Lineage | 15 | 2024 | 2539 | 0.530 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2017 | 3734 | 0.500 |
Why?
|
| Recombination, Genetic | 6 | 2017 | 1526 | 0.500 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2021 | 2821 | 0.480 |
Why?
|
| Wiskott-Aldrich Syndrome | 2 | 2014 | 130 | 0.480 |
Why?
|
| Cell-Penetrating Peptides | 2 | 2012 | 49 | 0.480 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 997 | 0.480 |
Why?
|
| Antigens, CD19 | 3 | 2020 | 425 | 0.480 |
Why?
|
| Macrophages | 13 | 2023 | 5764 | 0.480 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 2 | 2014 | 160 | 0.470 |
Why?
|
| Biotechnology | 1 | 2016 | 282 | 0.460 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2024 | 3590 | 0.460 |
Why?
|
| Granulocytes | 6 | 2019 | 550 | 0.460 |
Why?
|
| Insulator Elements | 1 | 2013 | 27 | 0.450 |
Why?
|
| Genome, Viral | 4 | 2017 | 665 | 0.440 |
Why?
|
| Genetic Loci | 2 | 2020 | 2626 | 0.440 |
Why?
|
| Cell Proliferation | 20 | 2024 | 10425 | 0.430 |
Why?
|
| Mice, Inbred NOD | 12 | 2021 | 1824 | 0.430 |
Why?
|
| Genetic Techniques | 1 | 2016 | 427 | 0.430 |
Why?
|
| RNA | 3 | 2020 | 2721 | 0.430 |
Why?
|
| Drug Substitution | 1 | 2016 | 288 | 0.430 |
Why?
|
| NF-kappa B | 1 | 2021 | 2485 | 0.420 |
Why?
|
| Cell Line, Tumor | 20 | 2024 | 16945 | 0.410 |
Why?
|
| Immunotherapy | 7 | 2023 | 4649 | 0.410 |
Why?
|
| Viruses | 1 | 2016 | 376 | 0.410 |
Why?
|
| Oncogenes | 2 | 2017 | 1223 | 0.410 |
Why?
|
| Ovarian Neoplasms | 3 | 2019 | 4879 | 0.400 |
Why?
|
| Cytokines | 12 | 2022 | 7377 | 0.400 |
Why?
|
| Molecular Biology | 1 | 2016 | 580 | 0.400 |
Why?
|
| Proviruses | 5 | 2024 | 313 | 0.390 |
Why?
|
| GA-Binding Protein Transcription Factor | 3 | 2016 | 43 | 0.390 |
Why?
|
| Interleukin-18 | 2 | 2024 | 249 | 0.390 |
Why?
|
| Transcription Factors | 14 | 2024 | 12121 | 0.380 |
Why?
|
| Epigenesis, Genetic | 5 | 2021 | 3782 | 0.380 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2011 | 439 | 0.370 |
Why?
|
| Chromatin | 7 | 2021 | 2951 | 0.370 |
Why?
|
| Hepatocytes | 6 | 2016 | 1232 | 0.370 |
Why?
|
| Morpholines | 1 | 2014 | 580 | 0.360 |
Why?
|
| Neoplastic Stem Cells | 2 | 2022 | 1347 | 0.360 |
Why?
|
| Signal Transduction | 14 | 2020 | 23397 | 0.360 |
Why?
|
| Immunologic Deficiency Syndromes | 5 | 2017 | 557 | 0.360 |
Why?
|
| RNA Viruses | 1 | 2011 | 111 | 0.360 |
Why?
|
| Embryonic Stem Cells | 5 | 2014 | 1262 | 0.350 |
Why?
|
| Mutation | 22 | 2023 | 30025 | 0.350 |
Why?
|
| Sequence Deletion | 2 | 2014 | 1494 | 0.340 |
Why?
|
| Mitochondria | 2 | 2023 | 3624 | 0.340 |
Why?
|
| RNA, Small Interfering | 11 | 2022 | 3428 | 0.340 |
Why?
|
| Chemokine CXCL12 | 3 | 2020 | 454 | 0.340 |
Why?
|
| MicroRNAs | 9 | 2018 | 3796 | 0.340 |
Why?
|
| Gene Expression Regulation | 14 | 2020 | 11900 | 0.340 |
Why?
|
| Recombinant Proteins | 6 | 2020 | 6525 | 0.330 |
Why?
|
| Antigens, CD34 | 10 | 2023 | 658 | 0.330 |
Why?
|
| Virion | 5 | 2012 | 422 | 0.330 |
Why?
|
| Tamoxifen | 1 | 2014 | 964 | 0.330 |
Why?
|
| Green Fluorescent Proteins | 12 | 2016 | 2060 | 0.330 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 2895 | 0.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2023 | 4575 | 0.320 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2020 | 169 | 0.320 |
Why?
|
| HEK293 Cells | 16 | 2021 | 4277 | 0.320 |
Why?
|
| Gene Expression Regulation, Leukemic | 5 | 2018 | 651 | 0.320 |
Why?
|
| Osteopetrosis | 2 | 2019 | 43 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 33 | 2024 | 22121 | 0.310 |
Why?
|
| Ribosomal Proteins | 5 | 2023 | 369 | 0.300 |
Why?
|
| Fetal Blood | 6 | 2022 | 1346 | 0.300 |
Why?
|
| Base Sequence | 16 | 2020 | 12449 | 0.300 |
Why?
|
| Receptors, Interferon | 2 | 2017 | 116 | 0.290 |
Why?
|
| Gene Knockdown Techniques | 6 | 2017 | 1610 | 0.290 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 4509 | 0.290 |
Why?
|
| HIV-1 | 8 | 2024 | 6859 | 0.290 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 2 | 2021 | 113 | 0.280 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2024 | 3609 | 0.280 |
Why?
|
| Gene Order | 5 | 2017 | 169 | 0.280 |
Why?
|
| Interleukin-10 | 2 | 2023 | 1176 | 0.270 |
Why?
|
| Umbilical Cord | 2 | 2019 | 179 | 0.270 |
Why?
|
| Virus Replication | 6 | 2017 | 2435 | 0.270 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2017 | 186 | 0.270 |
Why?
|
| Perforin | 2 | 2018 | 167 | 0.260 |
Why?
|
| Mice, Transgenic | 13 | 2021 | 9533 | 0.260 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 4 | 2020 | 629 | 0.260 |
Why?
|
| Clinical Trials as Topic | 9 | 2020 | 7996 | 0.250 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2017 | 114 | 0.250 |
Why?
|
| Septins | 2 | 2016 | 49 | 0.250 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2020 | 1337 | 0.250 |
Why?
|
| Stem Cells | 7 | 2023 | 3522 | 0.250 |
Why?
|
| Myocytes, Cardiac | 3 | 2024 | 1666 | 0.250 |
Why?
|
| Mice, SCID | 11 | 2017 | 2625 | 0.240 |
Why?
|
| Mice, Knockout | 15 | 2024 | 14397 | 0.240 |
Why?
|
| Cell Movement | 5 | 2021 | 5198 | 0.240 |
Why?
|
| Receptors, Notch | 2 | 2020 | 743 | 0.240 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2024 | 50 | 0.240 |
Why?
|
| Phenotype | 20 | 2024 | 16585 | 0.240 |
Why?
|
| alpha-Glucosidases | 1 | 2024 | 45 | 0.240 |
Why?
|
| Neutropenia | 3 | 2020 | 884 | 0.240 |
Why?
|
| RNA, Viral | 5 | 2017 | 2846 | 0.240 |
Why?
|
| Cell Survival | 9 | 2024 | 5790 | 0.240 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2024 | 43 | 0.230 |
Why?
|
| Dendritic Cells | 5 | 2018 | 2725 | 0.230 |
Why?
|
| Antibodies, Viral | 3 | 2024 | 3155 | 0.230 |
Why?
|
| Endonucleases | 3 | 2016 | 369 | 0.230 |
Why?
|
| Tumor Escape | 2 | 2018 | 370 | 0.230 |
Why?
|
| Antibodies, Neutralizing | 2 | 2024 | 1942 | 0.230 |
Why?
|
| Cytokinesis | 2 | 2016 | 171 | 0.230 |
Why?
|
| DNA-Binding Proteins | 8 | 2020 | 9598 | 0.230 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 7597 | 0.220 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2024 | 101 | 0.220 |
Why?
|
| Gangliosides | 1 | 2024 | 132 | 0.220 |
Why?
|
| HIV Long Terminal Repeat | 4 | 2024 | 85 | 0.220 |
Why?
|
| Immunophenotyping | 5 | 2021 | 1870 | 0.220 |
Why?
|
| Doxycycline | 3 | 2021 | 344 | 0.220 |
Why?
|
| Antineoplastic Agents | 6 | 2024 | 13616 | 0.220 |
Why?
|
| Usher Syndromes | 1 | 2023 | 56 | 0.220 |
Why?
|
| Spiral Ganglion | 1 | 2024 | 177 | 0.210 |
Why?
|
| Protein Binding | 6 | 2017 | 9340 | 0.210 |
Why?
|
| Codon | 3 | 2017 | 602 | 0.210 |
Why?
|
| DNA Transposable Elements | 3 | 2017 | 757 | 0.210 |
Why?
|
| Polymerase Chain Reaction | 10 | 2015 | 6086 | 0.210 |
Why?
|
| Stem Cell Transplantation | 4 | 2020 | 1598 | 0.210 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2018 | 269 | 0.210 |
Why?
|
| Cell Culture Techniques | 5 | 2018 | 1667 | 0.210 |
Why?
|
| Preleukemia | 2 | 2020 | 34 | 0.210 |
Why?
|
| Hemoglobinuria, Paroxysmal | 2 | 2014 | 95 | 0.200 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 2224 | 0.200 |
Why?
|
| Monocytes | 6 | 2017 | 2572 | 0.200 |
Why?
|
| Gamma Rays | 2 | 2021 | 318 | 0.200 |
Why?
|
| Virus Internalization | 3 | 2017 | 496 | 0.200 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2022 | 99 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2019 | 2803 | 0.200 |
Why?
|
| Myelopoiesis | 2 | 2020 | 134 | 0.200 |
Why?
|
| Urogenital Neoplasms | 1 | 2023 | 129 | 0.200 |
Why?
|
| Germany | 2 | 2021 | 873 | 0.200 |
Why?
|
| Myosins | 1 | 2023 | 405 | 0.200 |
Why?
|
| Cytidine Deaminase | 2 | 2015 | 245 | 0.200 |
Why?
|
| Peptide Hydrolases | 2 | 2023 | 621 | 0.200 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2011 | 223 | 0.200 |
Why?
|
| NFATC Transcription Factors | 2 | 2021 | 389 | 0.200 |
Why?
|
| Genes, Transgenic, Suicide | 3 | 2020 | 34 | 0.200 |
Why?
|
| Coculture Techniques | 3 | 2021 | 1340 | 0.190 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2021 | 58 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 2 | 2023 | 1959 | 0.190 |
Why?
|
| Hydrolases | 2 | 2013 | 147 | 0.190 |
Why?
|
| Hair Cells, Auditory | 1 | 2024 | 381 | 0.190 |
Why?
|
| Proteins | 2 | 2015 | 6033 | 0.190 |
Why?
|
| Antigens, Neoplasm | 3 | 2018 | 1994 | 0.190 |
Why?
|
| Genetic Drift | 1 | 2021 | 41 | 0.190 |
Why?
|
| beta-Globins | 1 | 2021 | 111 | 0.190 |
Why?
|
| Recombinases | 2 | 2024 | 66 | 0.190 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2021 | 126 | 0.190 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2021 | 28 | 0.190 |
Why?
|
| Skin Transplantation | 2 | 2024 | 1083 | 0.180 |
Why?
|
| Enhancer Elements, Genetic | 5 | 2013 | 1363 | 0.180 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2022 | 337 | 0.180 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2016 | 685 | 0.180 |
Why?
|
| GTP Phosphohydrolases | 3 | 2023 | 516 | 0.180 |
Why?
|
| Cloning, Molecular | 4 | 2017 | 4174 | 0.180 |
Why?
|
| Receptors, Colony-Stimulating Factor | 1 | 2020 | 50 | 0.180 |
Why?
|
| DNA Damage | 4 | 2021 | 2441 | 0.180 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2021 | 113 | 0.180 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2019 | 499 | 0.180 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2016 | 1393 | 0.180 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2020 | 109 | 0.180 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2020 | 72 | 0.180 |
Why?
|
| Interferon-gamma | 2 | 2019 | 3157 | 0.170 |
Why?
|
| Cell Transplantation | 3 | 2021 | 472 | 0.170 |
Why?
|
| Adipokines | 1 | 2022 | 310 | 0.170 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2020 | 105 | 0.170 |
Why?
|
| Caspase 9 | 1 | 2020 | 185 | 0.170 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 13312 | 0.170 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2020 | 157 | 0.170 |
Why?
|
| Adult Stem Cells | 2 | 2012 | 221 | 0.170 |
Why?
|
| Pseudogenes | 1 | 2019 | 103 | 0.170 |
Why?
|
| Bone Resorption | 3 | 2019 | 723 | 0.170 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 2 | 2019 | 196 | 0.170 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2020 | 92 | 0.170 |
Why?
|
| Sequence Homology | 1 | 2019 | 196 | 0.170 |
Why?
|
| Animals, Genetically Modified | 3 | 2021 | 1561 | 0.160 |
Why?
|
| Niacinamide | 2 | 2020 | 413 | 0.160 |
Why?
|
| Nerve Growth Factors | 1 | 2022 | 562 | 0.160 |
Why?
|
| beta-Thalassemia | 1 | 2021 | 236 | 0.160 |
Why?
|
| HLA-B Antigens | 1 | 2020 | 331 | 0.160 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 3874 | 0.160 |
Why?
|
| Thioredoxins | 2 | 2011 | 201 | 0.160 |
Why?
|
| Organ Specificity | 3 | 2020 | 1956 | 0.160 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2024 | 3072 | 0.160 |
Why?
|
| Jurkat Cells | 3 | 2016 | 739 | 0.160 |
Why?
|
| Interleukins | 2 | 2021 | 782 | 0.160 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2017 | 188 | 0.160 |
Why?
|
| Introns | 2 | 2019 | 981 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2021 | 4355 | 0.160 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 3 | 2015 | 85 | 0.160 |
Why?
|
| Viral Envelope Proteins | 5 | 2017 | 640 | 0.160 |
Why?
|
| Liver Cirrhosis | 2 | 2021 | 1934 | 0.150 |
Why?
|
| Host-Pathogen Interactions | 2 | 2017 | 1454 | 0.150 |
Why?
|
| Receptors, CCR7 | 1 | 2018 | 107 | 0.150 |
Why?
|
| Peptide Elongation Factor 1 | 3 | 2017 | 39 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2022 | 727 | 0.150 |
Why?
|
| Sialyltransferases | 1 | 2018 | 83 | 0.150 |
Why?
|
| Organoids | 1 | 2024 | 741 | 0.150 |
Why?
|
| Nuclear Proteins | 5 | 2016 | 5794 | 0.150 |
Why?
|
| Anemia, Aplastic | 4 | 2014 | 228 | 0.150 |
Why?
|
| DNA-Activated Protein Kinase | 2 | 2015 | 112 | 0.150 |
Why?
|
| Trans-Splicing | 1 | 2017 | 9 | 0.150 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2020 | 359 | 0.150 |
Why?
|
| Cochlea | 1 | 2024 | 845 | 0.150 |
Why?
|
| Collagen Type VII | 1 | 2017 | 22 | 0.150 |
Why?
|
| Interleukin-2 | 3 | 2021 | 1891 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2015 | 4567 | 0.150 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 2 | 2015 | 21 | 0.150 |
Why?
|
| Proto-Oncogenes | 4 | 2012 | 321 | 0.150 |
Why?
|
| DNA Methylation | 5 | 2021 | 4383 | 0.150 |
Why?
|
| Epidermolysis Bullosa Dystrophica | 1 | 2017 | 29 | 0.150 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 449 | 0.150 |
Why?
|
| Fanconi Anemia | 2 | 2012 | 324 | 0.150 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2017 | 29 | 0.150 |
Why?
|
| Transplantation, Autologous | 2 | 2020 | 2113 | 0.140 |
Why?
|
| K562 Cells | 6 | 2017 | 642 | 0.140 |
Why?
|
| Combined Modality Therapy | 4 | 2020 | 8522 | 0.140 |
Why?
|
| Reverse Transcription | 1 | 2017 | 47 | 0.140 |
Why?
|
| Leupeptins | 1 | 2017 | 113 | 0.140 |
Why?
|
| Transposases | 3 | 2013 | 104 | 0.140 |
Why?
|
| Cell Cycle | 7 | 2021 | 2929 | 0.140 |
Why?
|
| Bioreactors | 1 | 2018 | 247 | 0.140 |
Why?
|
| Leukopenia | 2 | 2015 | 213 | 0.140 |
Why?
|
| DNA Primers | 4 | 2015 | 2820 | 0.140 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2018 | 140 | 0.140 |
Why?
|
| Gene Knockout Techniques | 3 | 2016 | 802 | 0.140 |
Why?
|
| Cyclophilin A | 1 | 2017 | 58 | 0.140 |
Why?
|
| Mycobacterium bovis | 1 | 2017 | 147 | 0.140 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2017 | 85 | 0.140 |
Why?
|
| Mycobacterium Infections | 1 | 2017 | 122 | 0.140 |
Why?
|
| Chromosomal Instability | 2 | 2016 | 178 | 0.140 |
Why?
|
| Apoptosis | 7 | 2024 | 9468 | 0.140 |
Why?
|
| Lymphoma, B-Cell | 1 | 2023 | 940 | 0.140 |
Why?
|
| Single-Chain Antibodies | 1 | 2017 | 111 | 0.140 |
Why?
|
| Computer Systems | 1 | 2018 | 471 | 0.140 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2013 | 415 | 0.140 |
Why?
|
| Protective Agents | 1 | 2017 | 150 | 0.140 |
Why?
|
| Antibody Affinity | 1 | 2017 | 246 | 0.140 |
Why?
|
| Adoptive Transfer | 2 | 2024 | 819 | 0.140 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 500 | 0.140 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2016 | 22 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2021 | 1069 | 0.140 |
Why?
|
| Heart | 3 | 2024 | 4391 | 0.140 |
Why?
|
| Bone Marrow Transplantation | 3 | 2020 | 2693 | 0.140 |
Why?
|
| Precursor Cells, T-Lymphoid | 1 | 2016 | 19 | 0.130 |
Why?
|
| Phosphotransferases (Phosphomutases) | 1 | 2016 | 8 | 0.130 |
Why?
|
| RNA Interference | 4 | 2017 | 2832 | 0.130 |
Why?
|
| Models, Genetic | 4 | 2017 | 3445 | 0.130 |
Why?
|
| Pseudomonas Infections | 1 | 2020 | 622 | 0.130 |
Why?
|
| Enzyme Activation | 2 | 2019 | 3592 | 0.130 |
Why?
|
| Epitopes | 2 | 2020 | 2504 | 0.130 |
Why?
|
| Pulmonary Emphysema | 1 | 2021 | 685 | 0.130 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2016 | 50 | 0.130 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2020 | 1278 | 0.130 |
Why?
|
| Ligands | 2 | 2022 | 3270 | 0.130 |
Why?
|
| Erythropoiesis | 4 | 2023 | 682 | 0.130 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 1133 | 0.120 |
Why?
|
| Pyruvate Metabolism, Inborn Errors | 1 | 2016 | 49 | 0.120 |
Why?
|
| Cyclophosphamide | 1 | 2021 | 2218 | 0.120 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2015 | 189 | 0.120 |
Why?
|
| Interleukin-7 | 1 | 2015 | 142 | 0.120 |
Why?
|
| Viral Fusion Proteins | 1 | 2015 | 100 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2022 | 1339 | 0.120 |
Why?
|
| Gene Library | 1 | 2018 | 1059 | 0.120 |
Why?
|
| Anemia, Hemolytic, Congenital Nonspherocytic | 1 | 2016 | 55 | 0.120 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2016 | 132 | 0.120 |
Why?
|
| Adenylate Kinase | 1 | 2015 | 102 | 0.120 |
Why?
|
| Directed Molecular Evolution | 1 | 2016 | 158 | 0.120 |
Why?
|
| Glioblastoma | 2 | 2021 | 3481 | 0.120 |
Why?
|
| Stem Cell Factor | 2 | 2015 | 195 | 0.120 |
Why?
|
| Glycomics | 1 | 2016 | 112 | 0.120 |
Why?
|
| Spasms, Infantile | 1 | 2018 | 298 | 0.120 |
Why?
|
| Moloney murine leukemia virus | 2 | 2012 | 109 | 0.120 |
Why?
|
| Stilbenes | 1 | 2015 | 155 | 0.120 |
Why?
|
| Cyclosporine | 1 | 2017 | 778 | 0.120 |
Why?
|
| Pyruvate Kinase | 1 | 2016 | 189 | 0.120 |
Why?
|
| Sirolimus | 1 | 2021 | 1533 | 0.120 |
Why?
|
| Stathmin | 1 | 2014 | 70 | 0.120 |
Why?
|
| Gaucher Disease | 1 | 2015 | 110 | 0.120 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2014 | 40 | 0.120 |
Why?
|
| Myofibroblasts | 1 | 2016 | 208 | 0.120 |
Why?
|
| src-Family Kinases | 1 | 2017 | 535 | 0.120 |
Why?
|
| Neoplasm Proteins | 3 | 2021 | 3610 | 0.120 |
Why?
|
| Pyridines | 2 | 2024 | 2868 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2015 | 313 | 0.120 |
Why?
|
| Kinetics | 4 | 2015 | 6377 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 8519 | 0.110 |
Why?
|
| Lymphocytes | 2 | 2019 | 2610 | 0.110 |
Why?
|
| Regenerative Medicine | 2 | 2020 | 307 | 0.110 |
Why?
|
| Cytarabine | 2 | 2015 | 697 | 0.110 |
Why?
|
| Capsid Proteins | 1 | 2017 | 467 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2018 | 2647 | 0.110 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2017 | 726 | 0.110 |
Why?
|
| RNA, Untranslated | 1 | 2017 | 459 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2021 | 1611 | 0.110 |
Why?
|
| Repressor Proteins | 2 | 2019 | 2978 | 0.110 |
Why?
|
| Phagocytosis | 1 | 2019 | 1536 | 0.110 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 452 | 0.110 |
Why?
|
| DNA Modification Methylases | 2 | 2020 | 210 | 0.110 |
Why?
|
| Interleukin-21 Receptor alpha Subunit | 1 | 2013 | 18 | 0.110 |
Why?
|
| Ovalbumin | 1 | 2015 | 672 | 0.110 |
Why?
|
| Lentivirus Infections | 1 | 2013 | 11 | 0.110 |
Why?
|
| Multipotent Stem Cells | 1 | 2015 | 200 | 0.110 |
Why?
|
| Retroviridae Infections | 1 | 2013 | 147 | 0.110 |
Why?
|
| Mutagens | 1 | 2014 | 179 | 0.110 |
Why?
|
| Cell Death | 4 | 2023 | 1664 | 0.110 |
Why?
|
| Osteoclasts | 4 | 2019 | 711 | 0.110 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2015 | 431 | 0.110 |
Why?
|
| Gene Products, gag | 2 | 2012 | 312 | 0.110 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 2205 | 0.110 |
Why?
|
| Genes, Wilms Tumor | 1 | 2013 | 92 | 0.110 |
Why?
|
| Oligodendroglia | 1 | 2017 | 538 | 0.110 |
Why?
|
| Hazardous Substances | 1 | 2013 | 153 | 0.100 |
Why?
|
| CpG Islands | 2 | 2021 | 1225 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2017 | 1246 | 0.100 |
Why?
|
| Gene Expression Profiling | 10 | 2020 | 9410 | 0.100 |
Why?
|
| Genome, Human | 2 | 2016 | 4423 | 0.100 |
Why?
|
| Interleukin-6 | 2 | 2020 | 3209 | 0.100 |
Why?
|
| Biological Products | 1 | 2021 | 911 | 0.100 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2012 | 153 | 0.100 |
Why?
|
| Zinc Fingers | 2 | 2015 | 572 | 0.100 |
Why?
|
| Virus Shedding | 1 | 2013 | 111 | 0.100 |
Why?
|
| Keratinocytes | 2 | 2017 | 790 | 0.100 |
Why?
|
| Fanconi Anemia Complementation Group A Protein | 2 | 2012 | 50 | 0.100 |
Why?
|
| ras Proteins | 1 | 2017 | 1052 | 0.100 |
Why?
|
| Transfection | 4 | 2021 | 5776 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2024 | 3024 | 0.100 |
Why?
|
| Models, Biological | 6 | 2016 | 9462 | 0.100 |
Why?
|
| Thymidine Kinase | 2 | 2010 | 286 | 0.100 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2013 | 326 | 0.100 |
Why?
|
| Protein C | 1 | 2012 | 133 | 0.100 |
Why?
|
| Hepatitis B Virus, Woodchuck | 1 | 2011 | 6 | 0.100 |
Why?
|
| B-Lymphocytes | 7 | 2024 | 4748 | 0.100 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2013 | 296 | 0.100 |
Why?
|
| Membrane Glycoproteins | 4 | 2015 | 3701 | 0.100 |
Why?
|
| Thrombomodulin | 1 | 2012 | 105 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 343 | 0.100 |
Why?
|
| Tyrosinemias | 1 | 2011 | 10 | 0.100 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 4808 | 0.100 |
Why?
|
| Transcription Initiation Site | 1 | 2012 | 188 | 0.100 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2015 | 569 | 0.090 |
Why?
|
| Gene Knock-In Techniques | 1 | 2012 | 421 | 0.090 |
Why?
|
| Cystic Fibrosis | 1 | 2020 | 1284 | 0.090 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 345 | 0.090 |
Why?
|
| Coronary Artery Disease | 2 | 2021 | 6388 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 1753 | 0.090 |
Why?
|
| Epigenomics | 1 | 2017 | 940 | 0.090 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2011 | 72 | 0.090 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2013 | 628 | 0.090 |
Why?
|
| Female | 27 | 2024 | 391875 | 0.090 |
Why?
|
| Virus Activation | 1 | 2013 | 322 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 1010 | 0.090 |
Why?
|
| Transplantation, Heterologous | 2 | 2016 | 2385 | 0.090 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 88 | 0.090 |
Why?
|
| Cell Communication | 2 | 2019 | 1652 | 0.090 |
Why?
|
| Bone Regeneration | 1 | 2013 | 432 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1549 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2016 | 982 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4903 | 0.090 |
Why?
|
| Genetic Complementation Test | 1 | 2011 | 555 | 0.090 |
Why?
|
| Antioxidants | 2 | 2015 | 1670 | 0.090 |
Why?
|
| Esterases | 1 | 2010 | 98 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2018 | 1406 | 0.090 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 605 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2015 | 5292 | 0.090 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2010 | 62 | 0.090 |
Why?
|
| Nuclear Matrix | 1 | 2009 | 30 | 0.090 |
Why?
|
| Curcumin | 1 | 2011 | 98 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 2 | 2024 | 9176 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 3792 | 0.090 |
Why?
|
| Wnt Proteins | 1 | 2014 | 718 | 0.090 |
Why?
|
| Polyadenylation | 2 | 2009 | 117 | 0.090 |
Why?
|
| Carcinoma, Small Cell | 1 | 2012 | 420 | 0.090 |
Why?
|
| Hepacivirus | 1 | 2017 | 1337 | 0.090 |
Why?
|
| Parents | 1 | 2024 | 3563 | 0.080 |
Why?
|
| DNA, Circular | 1 | 2009 | 97 | 0.080 |
Why?
|
| Thymus Gland | 1 | 2014 | 1241 | 0.080 |
Why?
|
| Myocardial Ischemia | 1 | 2020 | 2110 | 0.080 |
Why?
|
| Retroelements | 1 | 2010 | 163 | 0.080 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2011 | 160 | 0.080 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2013 | 643 | 0.080 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2014 | 612 | 0.080 |
Why?
|
| Genes, Viral | 1 | 2010 | 649 | 0.080 |
Why?
|
| Mucopolysaccharidosis I | 1 | 2009 | 52 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2024 | 4923 | 0.080 |
Why?
|
| Antigens, CD | 3 | 2015 | 4000 | 0.080 |
Why?
|
| Liver | 3 | 2016 | 7531 | 0.080 |
Why?
|
| Hypercalcemia | 1 | 2012 | 423 | 0.080 |
Why?
|
| Hematopoietic System | 2 | 2024 | 110 | 0.080 |
Why?
|
| Deoxycytidine | 1 | 2013 | 874 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 2247 | 0.080 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2009 | 83 | 0.080 |
Why?
|
| Chromosome Disorders | 1 | 2011 | 499 | 0.080 |
Why?
|
| Gene Dosage | 4 | 2015 | 1218 | 0.080 |
Why?
|
| Microtubules | 1 | 2014 | 1074 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 326 | 0.080 |
Why?
|
| Genomic Instability | 3 | 2012 | 709 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4369 | 0.080 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 17639 | 0.080 |
Why?
|
| Ventricular Remodeling | 1 | 2016 | 1264 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 1766 | 0.080 |
Why?
|
| Escherichia coli | 2 | 2011 | 4234 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2015 | 1607 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1114 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 988 | 0.080 |
Why?
|
| Biological Evolution | 1 | 2014 | 1073 | 0.080 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2010 | 436 | 0.070 |
Why?
|
| RNA-Binding Proteins | 2 | 2014 | 1897 | 0.070 |
Why?
|
| RNA Splicing | 1 | 2012 | 915 | 0.070 |
Why?
|
| Aneuploidy | 1 | 2011 | 551 | 0.070 |
Why?
|
| Spinal Cord | 2 | 2017 | 1817 | 0.070 |
Why?
|
| Cholangiocarcinoma | 1 | 2013 | 552 | 0.070 |
Why?
|
| Bile Duct Neoplasms | 1 | 2013 | 605 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2010 | 457 | 0.070 |
Why?
|
| HIV Infections | 3 | 2024 | 17328 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3108 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 2204 | 0.070 |
Why?
|
| Regeneration | 2 | 2020 | 1508 | 0.070 |
Why?
|
| Simian immunodeficiency virus | 1 | 2012 | 808 | 0.070 |
Why?
|
| HeLa Cells | 5 | 2012 | 3097 | 0.070 |
Why?
|
| Virus Inactivation | 1 | 2007 | 20 | 0.070 |
Why?
|
| Cell Degranulation | 2 | 2019 | 276 | 0.070 |
Why?
|
| Trans-Activators | 3 | 2012 | 2858 | 0.070 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2016 | 891 | 0.070 |
Why?
|
| Male | 25 | 2023 | 360035 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2011 | 832 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2017 | 2907 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2017 | 1583 | 0.070 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2020 | 221 | 0.070 |
Why?
|
| Simian virus 40 | 1 | 2007 | 291 | 0.070 |
Why?
|
| Motor Neurons | 1 | 2011 | 868 | 0.070 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2006 | 84 | 0.070 |
Why?
|
| Sirtuins | 1 | 2009 | 320 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 2819 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2017 | 4936 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 4735 | 0.060 |
Why?
|
| Molecular Imaging | 1 | 2012 | 814 | 0.060 |
Why?
|
| DNA Repair Enzymes | 1 | 2007 | 346 | 0.060 |
Why?
|
| Tissue Scaffolds | 1 | 2012 | 934 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2006 | 562 | 0.060 |
Why?
|
| NAD | 1 | 2009 | 614 | 0.060 |
Why?
|
| Radiation Injuries | 1 | 2012 | 1185 | 0.060 |
Why?
|
| Graft Survival | 3 | 2024 | 3806 | 0.060 |
Why?
|
| Macrophages, Alveolar | 2 | 2019 | 412 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 1805 | 0.060 |
Why?
|
| Inflammation | 2 | 2020 | 10746 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2019 | 3777 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2007 | 1693 | 0.060 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2023 | 57 | 0.060 |
Why?
|
| Collagen | 1 | 2012 | 2637 | 0.050 |
Why?
|
| DNA Repair | 2 | 2016 | 2044 | 0.050 |
Why?
|
| Binding Sites | 2 | 2009 | 6042 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2016 | 3066 | 0.050 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2023 | 136 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 20078 | 0.050 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2024 | 419 | 0.050 |
Why?
|
| Homeostasis | 1 | 2014 | 3320 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2015 | 1841 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 1737 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2020 | 8311 | 0.050 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2022 | 151 | 0.050 |
Why?
|
| Radiation Tolerance | 2 | 2016 | 479 | 0.050 |
Why?
|
| Tissue Engineering | 1 | 2012 | 1870 | 0.050 |
Why?
|
| Nerve Endings | 1 | 2021 | 105 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2024 | 6206 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2015 | 1992 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2007 | 1091 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5296 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2023 | 389 | 0.050 |
Why?
|
| Qatar | 1 | 2021 | 40 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 11453 | 0.050 |
Why?
|
| Bone Marrow Diseases | 2 | 2014 | 232 | 0.050 |
Why?
|
| NIH 3T3 Cells | 2 | 2015 | 671 | 0.050 |
Why?
|
| Myeloablative Agonists | 1 | 2021 | 209 | 0.050 |
Why?
|
| Busulfan | 1 | 2021 | 258 | 0.050 |
Why?
|
| Cricetulus | 2 | 2015 | 815 | 0.050 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2013 | 170 | 0.050 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2011 | 1468 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2012 | 3306 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5236 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2023 | 3800 | 0.040 |
Why?
|
| Heart Failure | 2 | 2022 | 11653 | 0.040 |
Why?
|
| Cytomegalovirus | 3 | 2012 | 755 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 9003 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2024 | 697 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 1 | 2020 | 352 | 0.040 |
Why?
|
| Motor Vehicles | 1 | 2022 | 282 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2014 | 502 | 0.040 |
Why?
|
| CHO Cells | 2 | 2015 | 1389 | 0.040 |
Why?
|
| Mechanoreceptors | 1 | 2021 | 188 | 0.040 |
Why?
|
| Spleen Focus-Forming Viruses | 2 | 2011 | 16 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 2015 | 282 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3541 | 0.040 |
Why?
|
| Electrons | 1 | 2021 | 265 | 0.040 |
Why?
|
| Testis | 1 | 2023 | 794 | 0.040 |
Why?
|
| RNA Polymerase II | 2 | 2014 | 539 | 0.040 |
Why?
|
| Iron Overload | 1 | 2021 | 239 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2011 | 286 | 0.040 |
Why?
|
| HIV | 1 | 2007 | 1582 | 0.040 |
Why?
|
| Alleles | 2 | 2024 | 6908 | 0.040 |
Why?
|
| Culture Media | 2 | 2012 | 899 | 0.040 |
Why?
|
| Urologic Neoplasms | 1 | 2023 | 312 | 0.040 |
Why?
|
| Transplantation Tolerance | 1 | 2024 | 605 | 0.040 |
Why?
|
| Dependovirus | 2 | 2016 | 715 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2016 | 2911 | 0.040 |
Why?
|
| Cell Division | 2 | 2020 | 4461 | 0.040 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2019 | 85 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2020 | 410 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2022 | 1751 | 0.040 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 2011 | 119 | 0.040 |
Why?
|
| Lung | 3 | 2022 | 9973 | 0.040 |
Why?
|
| Azacitidine | 1 | 2020 | 336 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2011 | 3535 | 0.040 |
Why?
|
| Lymphocyte Activation | 3 | 2015 | 5491 | 0.040 |
Why?
|
| Mycobacterium avium | 1 | 2017 | 29 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2011 | 1745 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2019 | 522 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 3631 | 0.040 |
Why?
|
| Base Composition | 1 | 2018 | 290 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2020 | 384 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 979 | 0.040 |
Why?
|
| Protein Transport | 2 | 2015 | 1965 | 0.040 |
Why?
|
| Child, Preschool | 6 | 2018 | 42209 | 0.040 |
Why?
|
| Factor IX | 1 | 2017 | 77 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2020 | 496 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4319 | 0.040 |
Why?
|
| Algorithms | 1 | 2018 | 14002 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2014 | 1674 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2024 | 1359 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2010 | 5105 | 0.040 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2017 | 49 | 0.040 |
Why?
|
| HL-60 Cells | 2 | 2009 | 363 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2019 | 591 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2018 | 868 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2021 | 2265 | 0.040 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 103 | 0.040 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2018 | 178 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 2009 | 1545 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 1 | 2021 | 565 | 0.030 |
Why?
|
| Risk Factors | 5 | 2024 | 74055 | 0.030 |
Why?
|
| Tumor Burden | 2 | 2013 | 1887 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2018 | 944 | 0.030 |
Why?
|
| Serine | 1 | 2020 | 828 | 0.030 |
Why?
|
| Genome | 2 | 2015 | 1739 | 0.030 |
Why?
|
| Hemophilia B | 1 | 2017 | 84 | 0.030 |
Why?
|
| Basement Membrane | 1 | 2017 | 348 | 0.030 |
Why?
|
| Sensory Receptor Cells | 1 | 2021 | 512 | 0.030 |
Why?
|
| Ion Channels | 1 | 2021 | 1043 | 0.030 |
Why?
|
| Dicarbethoxydihydrocollidine | 1 | 2016 | 3 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 2019 | 700 | 0.030 |
Why?
|
| Quality Control | 1 | 2019 | 826 | 0.030 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2021 | 530 | 0.030 |
Why?
|
| Tacrolimus | 1 | 2020 | 733 | 0.030 |
Why?
|
| Lectins | 1 | 2018 | 491 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2017 | 212 | 0.030 |
Why?
|
| Aged | 5 | 2021 | 168840 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 943 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2017 | 150 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2020 | 1755 | 0.030 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 171 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2019 | 547 | 0.030 |
Why?
|
| Acridine Orange | 1 | 2015 | 28 | 0.030 |
Why?
|
| Pedigree | 2 | 2015 | 4586 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2018 | 468 | 0.030 |
Why?
|
| Safety | 2 | 2014 | 1150 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 613 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 934 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2021 | 1524 | 0.030 |
Why?
|
| Viral Proteins | 2 | 2013 | 1803 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2019 | 547 | 0.030 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2015 | 80 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2015 | 68 | 0.030 |
Why?
|
| Leukemia, Myeloid | 1 | 2018 | 694 | 0.030 |
Why?
|
| Measles virus | 1 | 2015 | 67 | 0.030 |
Why?
|
| Fibrosis | 1 | 2022 | 2048 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2024 | 2300 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 736 | 0.030 |
Why?
|
| Azo Compounds | 1 | 2015 | 117 | 0.030 |
Why?
|
| Lymphoma | 1 | 2004 | 1901 | 0.030 |
Why?
|
| Angiopoietins | 1 | 2015 | 85 | 0.030 |
Why?
|
| Prostate | 1 | 2023 | 1765 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2012 | 2014 | 0.030 |
Why?
|
| Vaccines, Subunit | 1 | 2015 | 161 | 0.030 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2014 | 42 | 0.030 |
Why?
|
| Pyridones | 1 | 2020 | 807 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2016 | 665 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2017 | 515 | 0.030 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2015 | 162 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2015 | 211 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2014 | 67 | 0.030 |
Why?
|
| Consensus | 1 | 2024 | 3115 | 0.030 |
Why?
|
| Genotype | 2 | 2021 | 12976 | 0.030 |
Why?
|
| Gastrula | 1 | 2014 | 82 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2015 | 198 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2017 | 351 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2015 | 264 | 0.030 |
Why?
|
| DNA Ligases | 1 | 2014 | 82 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2018 | 899 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2023 | 1588 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2015 | 609 | 0.030 |
Why?
|
| Deoxyribonucleases | 1 | 2015 | 211 | 0.030 |
Why?
|
| Blood Cells | 1 | 2016 | 305 | 0.030 |
Why?
|
| Glucosylceramidase | 1 | 2015 | 126 | 0.030 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2015 | 242 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fes | 1 | 2013 | 5 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2019 | 2676 | 0.030 |
Why?
|
| Neutrophils | 1 | 2006 | 3764 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 6128 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 2015 | 425 | 0.030 |
Why?
|
| Genes, APC | 1 | 2014 | 144 | 0.030 |
Why?
|
| Anthracyclines | 1 | 2015 | 284 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2019 | 10075 | 0.030 |
Why?
|
| Nucleotides | 1 | 2016 | 454 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2014 | 267 | 0.030 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2016 | 407 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2413 | 0.030 |
Why?
|
| Thrombopoietin | 1 | 2015 | 226 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2016 | 591 | 0.030 |
Why?
|
| Spleen | 1 | 2019 | 2296 | 0.030 |
Why?
|
| Infant | 4 | 2018 | 36183 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2017 | 653 | 0.030 |
Why?
|
| Cholestasis | 1 | 2016 | 377 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2014 | 428 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 1097 | 0.030 |
Why?
|
| Callithrix | 1 | 2012 | 94 | 0.030 |
Why?
|
| Pressure | 1 | 2016 | 1155 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2015 | 628 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 2180 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 604 | 0.030 |
Why?
|
| Catalysis | 1 | 2014 | 774 | 0.030 |
Why?
|
| Rats | 1 | 2008 | 23712 | 0.030 |
Why?
|
| Thrombopoiesis | 1 | 2014 | 165 | 0.030 |
Why?
|
| Time Factors | 3 | 2024 | 39947 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 471 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 855 | 0.020 |
Why?
|
| Swine, Miniature | 1 | 2014 | 961 | 0.020 |
Why?
|
| Superoxides | 1 | 2013 | 386 | 0.020 |
Why?
|
| Cell Dedifferentiation | 1 | 2012 | 122 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2012 | 130 | 0.020 |
Why?
|
| Glycolysis | 1 | 2016 | 832 | 0.020 |
Why?
|
| Aspergillus fumigatus | 1 | 2013 | 156 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 557 | 0.020 |
Why?
|
| Bioartificial Organs | 1 | 2012 | 47 | 0.020 |
Why?
|
| Nitrobenzoates | 1 | 2011 | 16 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Tetraploidy | 1 | 2011 | 28 | 0.020 |
Why?
|
| Anemia, Macrocytic | 1 | 2011 | 53 | 0.020 |
Why?
|
| Cyclohexanones | 1 | 2011 | 30 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 787 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2012 | 433 | 0.020 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 27 | 0.020 |
Why?
|
| Disease Progression | 3 | 2014 | 13484 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 11070 | 0.020 |
Why?
|
| Primates | 1 | 2014 | 523 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2012 | 262 | 0.020 |
Why?
|
| Magnetics | 1 | 2014 | 599 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2013 | 450 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2014 | 528 | 0.020 |
Why?
|
| Embryoid Bodies | 1 | 2011 | 65 | 0.020 |
Why?
|
| Models, Animal | 1 | 2017 | 2111 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2012 | 196 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 2011 | 317 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 6297 | 0.020 |
Why?
|
| Cell Shape | 1 | 2012 | 370 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 931 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2013 | 594 | 0.020 |
Why?
|
| Gliosis | 1 | 2011 | 244 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 2204 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 1759 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2012 | 901 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2015 | 1832 | 0.020 |
Why?
|
| Gap Junctions | 1 | 2012 | 230 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 532 | 0.020 |
Why?
|
| Embryo Transfer | 1 | 2014 | 522 | 0.020 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 381 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 915 | 0.020 |
Why?
|
| Nuclear Localization Signals | 1 | 2010 | 77 | 0.020 |
Why?
|
| Marmota | 1 | 2009 | 12 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2010 | 139 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2017 | 1273 | 0.020 |
Why?
|
| Chimerism | 1 | 2011 | 155 | 0.020 |
Why?
|
| Consanguinity | 1 | 2012 | 456 | 0.020 |
Why?
|
| Iduronidase | 1 | 2009 | 31 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2711 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2013 | 558 | 0.020 |
Why?
|
| Leukocytes | 1 | 2018 | 2024 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2020 | 7849 | 0.020 |
Why?
|
| Middle Aged | 7 | 2021 | 220382 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2017 | 888 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2013 | 1084 | 0.020 |
Why?
|
| Cations | 1 | 2010 | 238 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2013 | 1083 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2016 | 1014 | 0.020 |
Why?
|
| Metabolome | 1 | 2016 | 986 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2013 | 1130 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 592 | 0.020 |
Why?
|
| Endosomes | 1 | 2012 | 520 | 0.020 |
Why?
|
| Iran | 1 | 2012 | 738 | 0.020 |
Why?
|
| Platelet Count | 1 | 2011 | 780 | 0.020 |
Why?
|
| Comet Assay | 1 | 2008 | 72 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 870 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3661 | 0.020 |
Why?
|
| Copper | 1 | 2011 | 368 | 0.020 |
Why?
|
| Fluorescence | 1 | 2011 | 756 | 0.020 |
Why?
|
| Organ Size | 1 | 2013 | 2252 | 0.020 |
Why?
|
| Phosphoglycerate Kinase | 1 | 2008 | 66 | 0.020 |
Why?
|
| Solubility | 1 | 2010 | 1091 | 0.020 |
Why?
|
| Chromosomes | 1 | 2011 | 577 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4168 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2013 | 1143 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 1600 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2020 | 3059 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2012 | 987 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2016 | 3969 | 0.020 |
Why?
|
| Exons | 1 | 2014 | 2392 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 866 | 0.020 |
Why?
|
| Immunization | 1 | 2012 | 1226 | 0.020 |
Why?
|
| Viral Load | 1 | 2017 | 3329 | 0.020 |
Why?
|
| Peptides | 1 | 2020 | 4338 | 0.020 |
Why?
|
| Acute Disease | 1 | 2018 | 7230 | 0.020 |
Why?
|
| Lasers | 1 | 2012 | 951 | 0.020 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2007 | 27 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2007 | 30 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2009 | 245 | 0.020 |
Why?
|
| Endocytosis | 1 | 2012 | 958 | 0.020 |
Why?
|
| Mitomycin | 1 | 2008 | 262 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2024 | 23953 | 0.020 |
Why?
|
| Femur | 1 | 2013 | 1308 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 3603 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 1834 | 0.020 |
Why?
|
| Telomerase | 1 | 2012 | 745 | 0.020 |
Why?
|
| Gene Products, tat | 1 | 2007 | 111 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 2911 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2016 | 2417 | 0.020 |
Why?
|
| Metabolomics | 1 | 2016 | 1653 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2011 | 1397 | 0.020 |
Why?
|
| Adolescent | 3 | 2021 | 88196 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 755 | 0.020 |
Why?
|
| Survival Rate | 2 | 2013 | 12698 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2010 | 772 | 0.020 |
Why?
|
| tau Proteins | 1 | 2017 | 2091 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2012 | 1559 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 29551 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2008 | 213 | 0.020 |
Why?
|
| Cricetinae | 1 | 2009 | 2427 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1174 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 20985 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 2007 | 526 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 5427 | 0.020 |
Why?
|
| Adult | 5 | 2021 | 220781 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1741 | 0.020 |
Why?
|
| Colitis | 1 | 2014 | 1230 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3512 | 0.010 |
Why?
|
| Dogs | 1 | 2009 | 3839 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2006 | 451 | 0.010 |
Why?
|
| History, 21st Century | 1 | 2010 | 1567 | 0.010 |
Why?
|
| Child | 3 | 2021 | 80086 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2012 | 2667 | 0.010 |
Why?
|
| Swine | 1 | 2014 | 5915 | 0.010 |
Why?
|
| Tretinoin | 1 | 2007 | 519 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 13445 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 2468 | 0.010 |
Why?
|
| Ganciclovir | 1 | 2004 | 252 | 0.010 |
Why?
|
| Fetus | 1 | 2011 | 1863 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 2017 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2011 | 5031 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5662 | 0.010 |
Why?
|
| Zebrafish | 1 | 2015 | 3002 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 15257 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2012 | 4116 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 4108 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2014 | 2687 | 0.010 |
Why?
|
| Socialization | 1 | 1983 | 87 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3088 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2014 | 2478 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2012 | 2444 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1385 | 0.010 |
Why?
|
| Computational Biology | 1 | 2015 | 3510 | 0.010 |
Why?
|
| Preceptorship | 1 | 1983 | 56 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2013 | 1909 | 0.010 |
Why?
|
| DNA Replication | 1 | 2009 | 1418 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2010 | 2770 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 718 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2018 | 5764 | 0.010 |
Why?
|
| Aging | 1 | 2021 | 8689 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 3446 | 0.010 |
Why?
|
| Pregnancy | 2 | 2016 | 29831 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 10759 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2017 | 6570 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2870 | 0.010 |
Why?
|
| Motor Activity | 1 | 2011 | 2710 | 0.010 |
Why?
|
| Biological Transport | 1 | 2006 | 2090 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2006 | 1511 | 0.010 |
Why?
|
| Disease Transmission, Infectious | 1 | 2006 | 557 | 0.010 |
Why?
|
| Nursing Staff, Hospital | 1 | 1983 | 348 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2004 | 1387 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11729 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2006 | 2201 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2008 | 1296 | 0.010 |
Why?
|
| Neurons | 1 | 2018 | 9443 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 58859 | 0.010 |
Why?
|
| Calcium | 1 | 2012 | 5726 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2008 | 1889 | 0.010 |
Why?
|
| Skin | 1 | 2012 | 4474 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 15867 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2006 | 2906 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 6813 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2014 | 64591 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 17854 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 9267 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 22097 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 59068 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8466 | 0.010 |
Why?
|
| Brain | 1 | 2017 | 27060 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 41366 | 0.010 |
Why?
|
| Georgia | 1 | 1983 | 185 | 0.000 |
Why?
|
| Personnel Selection | 1 | 1983 | 195 | 0.000 |
Why?
|